Life Sciences Tools and Services
Company Overview of PBS Biotech, Inc.
PBS Biotech, Inc. designs and manufactures single-use bioreactor systems that grow a range of cell cultures used to develop drugs and vaccines. It offers 3 liter units and 500 liter stand-alone systems for clinical, seed train, and cGMP manufacturing. The company’s pneumatic bioreactor systems enable broad process applications for producing therapeutic proteins, monoclonal antibodies, viruses, vaccines, stem cells, personalized medicine, biosimilars, viral expansion/expression, batch process, fed-batch process, perfusion process, and transient transfection expression. Its products are available to biotechnology and pharmaceutical industries in the United States and internationally. The compa...
4023 Camino Ranchero
Camarillo, CA 93012
Founded in 2007
Key Executives for PBS Biotech, Inc.
Co-Founder and Member of the Advisory Board
Chief Financial Officer and Head of Business Development
Vice President of Research and Development
Vice President of Manufacturing and Operations
Compensation as of Fiscal Year 2013.
PBS Biotech, Inc. Key Developments
PBS Biotech, Inc. Signs Exclusive Distribution Agreement with Scrum Inc
May 2 13
PBS Biotech, Inc. has signed an exclusive distribution agreement with Scrum Inc. to market and sell its Single-Use Bioreactor technology in Japan. PBS Biotech makes next generation single-use bioreactors that grow a wide range of cell lines used to develop biological drugs and vaccines. The unique Air-Wheel(R) mixing system and innovative product design provide maximum operation efficiency with minimal space requirement. PBS Bioreactors are fully scalable from 3 liters to eventually 2,500 liters.
PBS Biotech, Inc. Signs Exclusive Distribution Agreement with DYNC B.V
Sep 13 12
PBS Biotech Inc. has signed an exclusive distribution agreement with DYNC B.V. to market and sell its Single Use Bioreactor technology into Europe. The initial focus will be on the German speaking countries, Belgium, Luxembourg and The Netherlands. PBS Biotech(R) makes the next generation single-use bioreactors that grow a wide range of cell cultures, used to develop biological drugs and vaccines. The unique Air-Wheel(TM) mixing system and innovative product design provide maximum operation efficiency with minimal space requirement. PBS Bioreactors are fully scalable from 3 liters to eventually 2,500 liters.
Andrew Gengos Joins PBS Biotech Inc's. Advisory Board
Feb 23 12
PBS Biotech Inc. announced that Andrew Gengos, President and CEO of Neuraltus Pharmaceuticals, has joined its Advisory Board. Mr. Gengos joined Neuraltus as CEO in February 2010. Andrew's significant biopharmaceutical industry leadership, strategy and business development experience will be of tremendous value to PBS Biotech as company bring innovative single-use bioreactor technology to market. Prior to joining Neuraltus, Mr. Gengos spent more than seven years with Amgen where he was Vice President, Strategy and Corporate Development.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|